These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 533263)

  • 1. Amikacin pharmacokinetics in pediatric patients with malignancy.
    Cleary TG; Pickering LK; Kramer WG; Culbert S; Frankel LS; Kohl S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):829-32. PubMed ID: 533263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose amikacin kinetics in pediatric oncology patients.
    Kramer WG; Cleary T; Frankel LS; Kohl S; Pickering LK
    Clin Pharmacol Ther; 1979 Nov; 26(5):635-40. PubMed ID: 498705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The necessity of increased doses of amikacin in burn patients.
    Zaske DE; Sawchuk RJ; Strate RG
    Surgery; 1978 Nov; 84(5):603-8. PubMed ID: 715674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 'high-dose' amikacin in children.
    Kumor KM; McDonald JM; Lietman PS
    Dev Pharmacol Ther; 1984; 7(6):368-76. PubMed ID: 6518944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular levels of amikacin after intravenous administration.
    Yogev R; Kolling WM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):583-6. PubMed ID: 7325626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
    Lode H; Grunert K; Koeppe P; Langmaack H
    J Infect Dis; 1976 Nov; 134 SUPPL():S316-22. PubMed ID: 825589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1312-7. PubMed ID: 782811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of amikacin dosage based upon lean body mass in patients with different renal function.
    Wagenvoort JH; Fieren MW; Goessens WH; Michel MF
    Chemotherapy; 1984; 30(2):69-75. PubMed ID: 6697814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of amikacin half-life during therapy in patients with renal insufficiency.
    Blaser J; Rüttimann S; Bhend H; Lüthy R
    Antimicrob Agents Chemother; 1983 Jun; 23(6):888-91. PubMed ID: 6614893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.
    Regeur L; Colding H; Jensen H; Kampmann JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):214-8. PubMed ID: 848923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and dose calculations of amikacin in the newborn.
    Sardemann H; Colding H; Hendel J; Kampmann JP; Hvidberg EF; Vejlsgaard R
    Clin Pharmacol Ther; 1976 Jul; 20(1):59-66. PubMed ID: 1277725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.
    Autret E; Marchand S; Breteau M; Grenier B
    Eur J Clin Pharmacol; 1986; 31(1):79-83. PubMed ID: 3780832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii N; Kojima S; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of amikacin in humans.
    Bodey GP; Valdivieso M; Feld R; Rodriguez V
    Antimicrob Agents Chemother; 1974 May; 5(5):508-12. PubMed ID: 4462465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.